Holliston

Harvard Bioscience initially fell out of Nasdaq compliance in April.

The company says the deal will allow customers to source a comprehensive range of precision tools from a single source, saving time and simplifying the procurement process.

Jim Green will retire from his roles as chairman, president, and CEO of Harvard Bioscience on July 28.

Harvard Bioscience, a Holliston-based biotech firm, has fallen out of compliance with Nasdaq stock exchange requirements following the resignation of a board of directors member.

Loewald’s departure comes after the CFO of the company resigned in May, after it reported a net loss of $12.4 million from fiscal 2024.

Officials from the Massachusetts Clean Energy Center met at Landry’s Bicycles in Worcester on Monday to unveil a new incentive program designed to make e-bikes more affordable for low- and moderate-income residents. 

The CFO of Harvard Bioscience in Holliston is set to step down from her role after a three-year stint with the company. 

The industrial park located off Route 16 was sold in a deal finalized on Wednesday.

Four Central Massachusetts businesses have received a combined $449,354 from a program designed to assist small and midsize manufacturers.

Twenty-three Central Massachusetts businesses made the 2024 Inc. 5000, an annual list of the nation’s 5000 fastest-growing companies compiled by Inc. magazine.